Evaluation of the Safety and Immunogenicity of Simultaneously Administration of EV71 Vaccine and Influenza Vaccine
Clinical trial NCT04091880 · COMPLETED
Trial details
- NCT number
- NCT04091880
- Sponsor
- China National Biotec Group Company Limited
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-26
- Primary completion
- 2020-01-06
- Enrollment
- 1134
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.